Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The Publications section now states that items are automatically filled from PubMed and may not be about the study. Revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:57:02.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice about government funding-related delays and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T01:43:17.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Results section has been added, including primary and secondary outcomes (ORR, DCR, DoR, PFS, OS) and updated study dates reflecting posted results.
    Difference
    0.4%
    Check dated 2025-10-28T02:45:59.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and updates the version to v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T15:50:36.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.1%
    Check dated 2025-09-29T09:46:30.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Upgrade to v3.0.2 from v3.0.1; removal of the 'Back to Top' element and no changes to core content.
    Difference
    0.1%
    Check dated 2025-09-14T23:30:50.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.